期刊文献+

择期PCI术相关性心梗的相关因素临床分析

Clinical Analysis of Related Factors of PCI-related Myocardial Infarction
下载PDF
导出
摘要 目的探讨经皮冠状动脉介入治疗(PCI)后并发相关性心梗的危险因素。方法方便选取2014年4月—2017年7月该院收治的90例PCI患者分为观察组(PCI相关性心梗,45例)和对照组(非PCI相关性心梗,45例)。观察两组资料并分析PCI相关性心梗危险因素。结果观察组术后低血压7例(15.6%),血hs-CRP(3.7±1.0)mg/L,支架总长度(39.4±13.6)mm,球囊扩张次数(2.6±0.5)次,靶血管多枚支架植入22例(48.9%),与对照组比较差异有统计学意义(P<0.05)。结论术后低血压、hs-CRP、支架总长度、球囊扩张次数、靶血管多枚支架植入是PCI相关性心梗的独立危险因素。 Objective This paper tries to explore the risk factors of percutaneous coronary intervention(PCI) complicated with associated myocardial infarction. Methods 90 cases of PCI patients in this hospital from April 2014 to July 2017 were convenient selection and divided into the observation group(PCI related myocardial infarction, 45 cases) and the control group(non PCI related myocardial infarction, 45 cases). The risk factors of PCI-related myocardial infarction of the two groups were observed. Results Postoperative hypotension in the observation group was 7 cases(15.6%), the blood hs-CRP of(3.7±1.0) mg/L, the total length of the stent of(39.4±13.6)mm, times of balloon of(2.6±0.5) times, a plurality of target vessel stent implantation of 22 cases(48.9%), there was statistically significant difference compared with the control group(P〈0.05).Conclusion Postoperative hypotension, hs-CRP, total stent length, number of balloon dilation and multiple stent implantation were independent risk factors of PCI related myocardial infarction.
出处 《中外医疗》 2017年第33期85-87,共3页 China & Foreign Medical Treatment
关键词 PCI 相关性心梗 危险因素 PCI Related myocardial infarction Risk factors
  • 相关文献

参考文献7

二级参考文献81

  • 1田颖,祝善俊,王江.神经内分泌拮抗治疗慢性心力衰竭的几个热点问题[J].中华心血管病杂志,2005,33(5):485-488. 被引量:42
  • 2Roger VL,Go AS,Lloyd -Jones DM,et al.Heart disease and stroke statistics--2011 update:a report from the American Heart Association.Circulation,2011,123:e18-209.
  • 3Herrmann J.Peri-procedural myocardial injury:2005 update.Eur Heart J,2005,26:2493-2519.
  • 4Tardiff BE,Califf RM,Tcheng JE,et al.Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention.IMPACT-Ⅱ Investigators.Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-Ⅱ.J Am Coll Cardiol,1999,33:88-96.
  • 5Thygesen K,Alpert JS,White HD,et al.Universal definition of myocardial infarction.irculation,2007,116:2634-2653.
  • 6Smith SC,Dove JT,Jacobs AK,et al.ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary:a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty)endorsed by the Society for Cardiac Angiography and Interventions.Circulation,2001,103:3019-3041.
  • 7Miller WL,Garratt KN,Burritt MF,et al.Baseline troponin level:key to understanding the importance of post-PCI troponin elevations.Eur Heart J,2006,27:1061-1069.
  • 8Testa L,Van Gaal WJ,Biondi Zoccai GG,et al.Myocardial infarction after percutaneous coronary intervention:a meta-analysis of troponin elevation applying the new universal definition.QJM,2009,102:369-378.
  • 9Gomez-Hospital JA,Cequier A,Valero J,et al.Minor myocardial damage during percutaneous coronary intervention does not affectlong-term prognosis.Rev Esp Cardiol,2009,62:625-632.
  • 10Stone GW,McLaurin BT,Cox DA,et al.Bivalirudin for patients with acute coronary syndromes.N Engl J Med,2006,355:2203-2216.

共引文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部